Last reviewed · How we verify
NCT05894811
A Study on the Effect of Bariatric Surgery on Glucose Metabolism in Chinese Obese and Type 2 Diabetes Patients
trial testing oral glucose tolerance test in Diabete Type 2 in 48 participants. Not yet recruiting.
1 June 2026
Quick facts
| Lead sponsor | Dongyang Liu |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 48 |
| Start date | 1 June 2023 |
| Primary completion | 1 June 2026 |
| Estimated completion | 1 December 2026 |
Drugs / interventions tested
- oral glucose tolerance test — full drug profile →
- MRI — full drug profile →
Conditions studied
- Diabete Type 2 — all drugs for Diabete Type 2 →
- Obesity — all drugs for Obesity →
Sponsor
Dongyang Liu
Who can join
Adults 16 to 65, any sex, with Diabete Type 2 or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will be conducted in the following population: obese patients with normal glucose tolerance (HbA1c ≤ 5.6%, n=12), pre-sugar patients (5.7% ≤ HbA1c ≤ 6.4%, n=18) and patients with T2DM (HbA1c ≥ 6.4% , n=18). After recruiting, they were followed up at 1, 3, 6, and 12 months postoperatively, and their preoperative and follow-up examination values related to demographics, body composition, blood biochemistry, and glucose metabolic balance, as well as quantitative MRI imaging and oral glucose tolerance test (OGTT) will be collected. An interim analysis will be performed at 6 months postoperatively and overall analysis will be performed at 12 months postoperatively by descriptive statistics and ANOVA methods to explore the effect of adiposity on the progression of diabetes mellitus and insulin secretory function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05894811
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of oral glucose tolerance test
Trials testing the same drug.
- NCT05463237 — Comparison of Visceral Adipokines Visfatin, Vaspin and Omentin Levels in Gestational Diabetes Mellitus Pregnant Women · completed
- NCT04633109 — The Obese Taste Bud Study · unknown
- NCT04038086 — Transport of Satiety Factors Into the CSF · NA · unknown
- NCT05148130 — Construction and Biological Study of Blood and Placenta Samples Associated With Gestational Diabetes Mellitus · unknown
- NCT03041129 — Post-Prandial Liver Glucose Metabolism in PCOS · completed
Other recruiting trials for Diabete Type 2
Currently open trials in the same condition.
- NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
- NCT07467460 — Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disea · recruiting
- NCT07469943 — The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness a · recruiting
- NCT07495787 — Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative · NA · recruiting
- NCT07212075 — Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups · recruiting
Other Dongyang Liu trials
Trials by the same sponsor.
- NCT05715658 — Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects · NA · unknown
- NCT05207852 — Clinical Pharmacology of Dexamethasone in Pregnant Women With Preterm Labor · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05894811 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dongyang Liu
- Last refreshed: 8 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05894811.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing